Bruce D. Weintraub
Amministratore Delegato presso Trophogen, Inc.
Posizioni attive di Bruce D. Weintraub
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Trophogen, Inc.
 Trophogen, Inc. BiotechnologyHealth Technology Trophogen, Inc. develops glycoprotein hormones and therapeutic applications. The firm's research is focused on developing super-agonists and antagonists of cystine knot growth factors and therapy and imaging of thyroid, ovarian, breast, prostate and testicular cancers. The company was founded by Bruce D. Weintraub and Mariusz W. Szkudlinski in July 2001 and is headquartered in Rockville, MD. | Amministratore Delegato | 01/07/2001 | - |
| Fondatore | 25/02/2010 | - | |
| Presidente | 01/07/2001 | - | |
| Direttore operativo | 01/07/2001 | 21/01/2013 | |
| Direttore Tecnico/Scientifico/R&S | 01/07/2001 | 21/01/2013 |
Storia della carriera di Bruce D. Weintraub
Precedenti posizioni note di Bruce D. Weintraub
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| University of Maryland | Corporate Officer/Principal | 01/01/1996 | 01/01/2001 |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
| The Endocrine Society | Corporate Officer/Principal | - | - |
Formazione di Bruce D. Weintraub
| Princeton University | Undergraduate Degree |
| Harvard University | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
Posizioni
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 1 |
| Chief Operating Officer | 1 |
Settori
| Consumer Services | 4 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Trophogen, Inc.
Trophogen, Inc. BiotechnologyHealth Technology Trophogen, Inc. develops glycoprotein hormones and therapeutic applications. The firm's research is focused on developing super-agonists and antagonists of cystine knot growth factors and therapy and imaging of thyroid, ovarian, breast, prostate and testicular cancers. The company was founded by Bruce D. Weintraub and Mariusz W. Szkudlinski in July 2001 and is headquartered in Rockville, MD. | Health Technology |
| The Endocrine Society |
- Borsa valori
- Insiders
- Bruce D. Weintraub
- Esperienza
